Skip to main content
. Author manuscript; available in PMC: 2012 Dec 10.
Published in final edited form as: Oncol Rep. 2011 Jul 1;26(4):995–1002. doi: 10.3892/or.2011.1372

Figure 1.

Figure 1

qPCR validations of selected miRNAs. Log fold change is shown for both the TLDA array and the miR-specific qPCR assay for endometrioid adenocarcinoma and serous adenocarcinoma. Significant values (*p<0.05 and **p<0.01) are comparing adenocarcinoma with benign endometrium.